Paid Clinical Trials in Englewood, NJ
As of August 2026, 39 paid clinical trials are recruiting in Englewood, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Englewood offers studies at sites including Englewood Hospital and Medical Center for conditions such as Coronary Artery Disease, Healthy Volunteer, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Englewood
Trials by drug in Englewood
Filter results
34 clinical trials
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
SELUTION 4 De Novo Small Vessel IDE Trial
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
A Retrospective Assessment of OviTex PRS (OviTex)
A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ultralow Dose PET Imaging for 18F-NaF Uptake
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
One-Month DAPT in CABG Patients
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-
Ultralow Dose PET Imaging of 18F-FDG Uptake
Ultralow Dose PET Imaging for PSMA Expression
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery
Fecal Microbiota Transplantation for C Diff Infection
Top Research Study Locations in Englewood
Researchers run research studies in Englewood, NJ at 10 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Englewood Hospital and Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 16 |
| Nuclear Imaging Institute | Healthy Volunteer, Healthy Volunteers, Neuroendocrine (NE) Tumors | 7 |
| Englewood Hospital | Coronary Artery Disease, Cardiac Surgery, Chronic Coronary Disease | 7 |
| Englewood Health | Coronary Artery Disease, Anorexia Nervosa with Significantly Low Body Weight, Coronary Artery Bypass Grafting | 4 |
| Clinical Research dep. Davison Place. Englewood Health | Brain Tumor, Brain Tumor - Metastatic, Brain Tumor, Adult Meningioma | 1 |
| David L. Abramson, MD | Reconstructive Surgical Procedures | 1 |
| Decentralized Study Coordinating Center | Psoriasis | 1 |
| Englewood Hospital & Med Center | Vein Disease, Vein Occlusion, Vein Thrombosis | 1 |
| Health East ASC | Lumbar Spinal Stenosis | 1 |
| Patient Care Associates | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Englewood (2026)
Recruiting trials in Englewood grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (17 active studies)
- Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy · Englewood Hospital and Medical Center
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab · Phase 3 · Alliance for Clinical Trials in Oncology
Cardiovascular (7 active studies)
- Ultralow Dose PET Imaging of 18F-flurpiridaz · Phase 2 · Akiva Mintz
- Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery · EARLY_Phase 1 · Englewood Hospital and Medical Center
Neurology & pain (1 active study)
- Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol · Phase 2 · Akiva Mintz
Common conditions studied in Englewood
- Coronary Artery Disease (4 active studies)
- Healthy Volunteer (4 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage IIIB Breast Cancer AJCC v8 (2 active studies)
Leading research sponsors in Englewood
- Akiva Mintz
- Englewood Hospital and Medical Center
- Alliance for Clinical Trials in Oncology
- Weill Medical College of Cornell University
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Englewood?
There are approximately 39 recruiting clinical trials in Englewood, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Englewood pay participants?
Most recruiting trials in Englewood compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Englewood?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Englewood?
The most common conditions under active study in Englewood include Coronary Artery Disease (4), Healthy Volunteer (4), Anatomic Stage II Breast Cancer AJCC v8 (3), Anatomic Stage I Breast Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Englewood?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Englewood on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Englewood?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Englewood?
Recruiting research sites in Englewood include Englewood Hospital and Medical Center, Nuclear Imaging Institute, Englewood Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Englewood right now?
The largest active categories in Englewood are Cancer & tumors (17), Cardiovascular (7), Neurology & pain (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.